Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Precision Delivery of Siponimod through Nanoemulsions: Shaping the Future of Multiple Sclerosis Management

Multiple Sclerosis (MS) is a chronic immune-mediated neurodegenerative disorder characterized by demyelination of myelin, neuroinflammatory neurons, and progressive neuronal loss. Although several disease-modifying treatments are available, some of these drugs are not easily bioavailable, cannot penetrate the Blood...

K. Ravi, K. Arora · 0 citations
Review Sep 2026

Advancement and Challenges in Multiple Sclerosis: Understanding the Disease from Etiology to Treatment.

Multiple Sclerosis (MS) is a chronic immune-mediated neurodegenerative disorder of the Central Nervous System (CNS) that affects more than 2.8 million people worldwide. It is recognized as one of the leading causes of non-traumatic neurological disability among young adults. It is an inflammatory demyelination disease...

K. Ravi, K. Arora · 0 citations
Review Aug 2026

Advancing Pharmacovigilance: AI and Deep Learning Approaches to Detect Adverse Drug Reactions from Big Data

The results indicate the potential for substantial improvements in current pharmacovigilance systems through the use of AI-based models that can identify latent relationships and deliver safety alerts in near-real time.

C. R. Darwin, Meruva Sathish Kumar, S. Marakatham et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.